Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May 13:3:29.
doi: 10.3389/fcell.2015.00029. eCollection 2015.

Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges

Ramzey Abujarour  1 , Bahram Valamehr  1
Affiliations
Review

Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges

Ramzey Abujarour et al. Front Cell Dev Biol. .

Abstract

Human pluripotent stem cells (hPSCs) possess unlimited proliferative potential while maintaining the ability to differentiate into any cell type including skeletal muscle cells (SMCs). hPSCs are amenable to genetic editing and can be derived from patient somatic cells, and thus represent a promising option for cell therapies for the treatment of degenerative diseases such as muscular dystrophies. There are unresolved challenges however associated with the derivation and scale-up of hPSCs and generation of differentiated cells in large quantity and high purity. Reported myogenic differentiation protocols are long, require cell sorting and/or rely on ectopic expression of myogenic master regulators. More recent advances have been made with the application of small molecules to enhance the myogenic differentiation efficiency and the identification of more selective markers for the enrichment of myogenic progenitors with enhanced regenerative potential. Here we review the field of myogenic differentiation and highlight areas requiring further research.

Keywords: IPSC; MyoD; myogenic differentiation; pax7; pluripotent; satellite cells; skeletal muscle; skeletal muscle cells.

PubMed Disclaimer

References

    1. Abujarour R., Bennett M., Valamehr B., Lee T. T., Robinson M., Robbins D., et al. (2014). Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery. Stem Cells Trans. Med. 3, 149–160. 10.5966/sctm.2013-0095 - DOI - PMC - PubMed
    1. Abujarour R., Valamehr B., Robinson M., Rezner B., Vranceanu F., Flynn P. (2013). Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection. Sci. Rep. 3, 1179. 10.1038/srep01179 - DOI - PMC - PubMed
    1. Albini S., Coutinho P., Malecova B., Giordani L., Savchenko A., Forcales S. V., et al. (2013). Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres. Cell Rep. 3, 661–670. 10.1016/j.celrep.2013.02.012 - DOI - PMC - PubMed
    1. Awaya T., Kato T., Mizuno Y., Chang H., Niwa A., Umeda K., et al. (2012). Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells. PLoS ONE 7:e51638. 10.1371/journal.pone.0051638 - DOI - PMC - PubMed
    1. Barberi T., Bradbury M., Dincer Z., Panagiotakos G., Socci N. D., Studer L. (2007). Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat. Med. 13, 642–648. 10.1038/nm1533 - DOI - PubMed